Chemotherapy-induced alopecia (CIA) in breast cancer patients: effectiveness of two temperature levels of scalp cooling on reducing rates of CIA.

Not Applicable

Active, not recruiting

• Conditions: chemotherapy-induced alopecia; breast cancer; Cancer - Breast

• Registration Number: ACTRN12615001106527
• Lead Sponsor: Breast Cancer Research Centre of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-21
• Last Update Posted: 12 April 2021

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 63

Inclusion Criteria

histologically confirmed invasive breast cancer
- suitable to receive one of the approved chemotherapy regiments, defined in the protocol, in the neo/adjuvant or metastatic setting
- minimum understanding of English language to complete quality of life questionnaire
- willingness to be followed for 10 years

Exclusion Criteria

- history of malignant primary brain tumour
- history of scalp or brain metastasis
- recommended chemotherapy given on weekly schedule
- patient suffering from cold sensitivity, cold agglutinin disease, cryoglobulinemia, cryofibrogenemia or cold traumatic dystrophy
- prior chemotherapy for any reason
- allergy to silicon
- concurrent treatment affecting hair growth

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of patient reported minimal CIA (Dean's score 1/2 OR WHO grade 1/2) after completion of planned chemotherapy in this clinical setting compared to the population overall[End of chemotherapy]